Hiroyuki Konya

Continuous stimulation of human glucagon-like peptide-1 (7–36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes

Jianfa Zhang, Yae Tokui, Kazuya Yamagata et al. · Diabetologia · 2007 · 75 citations · Full text

Autoimmune Type 1, Autoimmune Disease, Diabetes +12

Modification of dopamine release by nociceptin in conscious rat striatum

Hiroyuki Konya, Hiroshi Masuda, Kiyofumi Itoh et al. · Brain Research · 1998 · 43 citations

Health Sciences, Neurophysiology, Neuroanatomy +11

Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes

K. Satani, Hiroyuki Konya, Tomoya Hamaguchi et al. · Diabetic Medicine · 2006 · 32 citations

Modification of acetylcholine release by nociceptin in conscious rat striatum

Kiyofumi Itoh, Hiroyuki Konya, Eri Takai et al. · Brain Research · 1999 · 27 citations

Health Sciences, Neurophysiology, Neuroanatomy +12

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus

Hiroyuki Konya, Yoshikazu Hasegawa, Tomoya Hamaguchi et al. · Metabolism · 2010 · 20 citations

Thrombosis, Diabetes Management, Cardiovascular Disease +12